X4 Pharmaceuticals (NASDAQ:XFOR) Stock Quotes, Forecast and News Summary

Q: What sector and industry does X4 Pharmaceuticals (XFOR) operate in?

X4 Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

X4 Pharmaceuticals Stock (NASDAQ: XFOR) stock price, news, charts, stock research, profile.

Open	$0.50
Close	$0.49
Volume / Avg.	1.71M / 3.67M
Day Range	$0.47 - $0.53
52 Wk Range	0.26 - 1.60
Market Cap	$81.90M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	7.9%
Days to Cover	4.75

Recent News

5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More

Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach.

Shanthi Rexaline

FDA Approves X4 Pharmaceuticals' Mavorixafor As First Therapy For Rare Immunodeficiency Disorder

FDA approves Xolremdi capsules for WHIM syndrome, boosting neutrophil & lymphocyte counts. First therapy for this rare immunodeficiency disorder. Potential sales forecasted at $54.6M in 2024, rising to $450.9M by 2027.

Vandana Singh

Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.50
Close	$0.49
Volume / Avg.	1.71M / 3.67M
Day Range	$0.47 - $0.53
52 Wk Range	0.26 - 1.60
Market Cap	$81.90M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	7.9%
Days to Cover	4.75

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy X4 Pharmaceuticals (XFOR) stock?

You can purchase shares of X4 Pharmaceuticals (NASDAQ:XFOR) through any online brokerage.

View our list of the best stock brokerages

Who are X4 Pharmaceuticals (XFOR) competitors?

Other companies in X4 Pharmaceuticals’s space includes: Skye Bioscience (NASDAQ:SKYE), Adverum Biotechnologies (NASDAQ:ADVM), bluebird bio (NASDAQ:BLUE), Inozyme Pharma (NASDAQ:INZY) and Citius Oncology (NASDAQ:CTOR).

What is the forecast, or price target, for X4 Pharmaceuticals (XFOR) stock?

X4 Pharmaceuticals has a consensus price target of $3.94.

What is the current price for X4 Pharmaceuticals (XFOR)?

The stock price for X4 Pharmaceuticals (NASDAQ: XFOR) is $0.4802 last updated January 21, 2025 at 5:34 PM EST.

Does X4 Pharmaceuticals (XFOR) pay a dividend?

There are no upcoming dividends for X4 Pharmaceuticals.

When is X4 Pharmaceuticals (NASDAQ:XFOR) reporting earnings?

X4 Pharmaceuticals’s Q4 earnings are confirmed for Thursday, March 20, 2025.

Is X4 Pharmaceuticals (XFOR) going to split?

There is no upcoming split for X4 Pharmaceuticals.

What sector and industry does X4 Pharmaceuticals (XFOR) operate in?

X4 Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

X4 Pharmaceuticals

X4 Pharmaceuticals (XFOR) Forecast